Category: Regulatory and Drug Development Terminology
Post-Marketing Surveillance
The ongoing collection and assessment of safety information after a treatment becomes available for clinical use. In DMD, post-marketing surveillance can help identify uncommon or delayed adverse events and improve understanding of treatment safety in broader populations.
- Updated November 3, 2026